Comparison of Dexmedetomidine 50μg versus 100μg added to 0.5% Levobupivacaine in Supraclavicular Brachial Plexus Block (BPB) for Arteriovenous Fistula (AVF) Surgery by Chong, Soon Eu et al.
Chong SE, Mohd, Mohd Nikman A, Fakhzan H,
Rhendra Hardy MZ, W Mohd Nazarudin WH
Dept of Anaesthesia & Intensive Care, 
School of Medical Science, Universiti Sains Malaysia
Comparison of 
Dexmedetomidine 50μg versus 100μg 
added to 0.5% Levobupivacaine in 
Supraclavicular Brachial Plexus Block (BPB) 
for Arteriovenous Fistula (AVF) Surgery
• AVF Surgery : a procedure to attach the vein to the 
artery & prepare a patient for hemodialysis.
• Normally done under LA
• Alternatively, it can be done under RA, with better 
analgesia coverage.
• Currently various drugs has been proven to be 
effective adjuncts to brachial plexus block: opioids, 
clonidine, neostigmine, and tramadol.
(DB. Murphy, Anesth Analg 2000) 
INTRODUCTION
• The search on a suitable LA + additive which 
is faster in onset, longer duration, stable 
haemodynamically, and better in safety profile 
is still in progress.
INTRODUCTION
INTRODUCTION
• Dexmedetomidine (dex) is one of the latest α2-agonist.
• provides sedation without causing respiratory depression.
• Normally used as sedation in anaesthesia & ICU.
• Studies on the effect of dexmedetomidine as additive in 
brachial plexus block is still on-going.
DEXMEDETOMIDINE
1. High lipid solubility - rapidly absorbs and 
binds to the α2 receptor of the nerves for 
faster analgesic effect. 
2. Central and peripheral enhancement of LA 
activity causing prolongation of nerve block. 
(Schnaider et al. 2005, 
Kanazi et al. 2006)
OBJECTIVE
• To compare the effect of adding Dexmedetomidine
50μg versus 100μg to 0.5% Levobupivacaine in 
Supraclavicular BPB for AVF Surgery in terms of: 
1. Onset and Duration of block, 
2. Sedation effect and Haemodynamic parameters,
3. Changes in Vascular diameters.
STUDY DESIGN
• Double blinded RCT, done in OT HUSM after ethical 
committee approval.
• Sample size calculated by using the difference of means 
from Esmaoglu’s study (2010) which compare: 
Dex 100μg versus placebo added to Levobupivacaine in 
Axillary Block. (ESRF patient were excluded)
• Alpha = 0.05  ( level of significance )
• Power = 0.8
• Mean onset time in placebo (1) 9.13
• Difference in mean 10.46-9.13 = 1.33min (SD)
• Sample size is 23 patients for each arm.
METHODOLOGY
Selection of patient
N = 46
ESRF for AVF
> 18 y/o, Well fasted 
Full GCS, consented
Exclusion criterias
Block randomization
Dex 50 μg + 
0.5ml NS + 20ml  
0.5% Levo
Dex 100 μg  + 
20ml  0.5% Levo
U/S guided 
supraclavicular block
vital signs, VAS, Onset of 
block (sensory, motor),
brachial. a. & basilic. v. 
diameters (by ultrasound)
surgery
vital signs,
Ramsay Sedation Score,
Duration of block, 
(sensory, motor)
RESULT
• Demographic Data:
• No significant differences between the two 
groups in terms of age, gender, weight and 
height. 
*  Independent T-test
**  Statistically significant
P value * 0.002**
*  Independent T-test
**  Statistically significant
P value * 0.024**
*  Independent T-test
**  Statistically significant
P value * <0.001**
*  Independent T-test
**  Statistically significant
P value * 0.002**
Ramsay Sedation score
*Chi-Square
** Statistically 
not significant
sedated
MEAN ARTERIAL PRESSURE COMPARISON
Repeated Measure  
ANOVA:    
Statistically not 
significant 
(p=0.581)
HEART RATE COMPARISON
Repeated Measure  
ANOVA:    
Statistically not 
significant 
(p=0.078)
VESSEL DIAMETER DIFFERENCE
PRE & POST BLOCK
*  Statistically significant
Vessel DEX 50 DEX 100
Mean (SD) Mean (SD) t(44) p-value
Brachial artery 0.020 (0.0067) 0.025 (0.0059) 2.55 0.014*
Basilic Vein 0.022 (0.0074) 0.027 (0.0062) 2.60 0.013*
DISCUSSION
• Result was similar to Esmaoglu’s 2010 study, 
where Dexmedetomidine 100μg versus 
placebo were added to 0.5% Levobupivacaine
in Axillary Block. 
• Dexmedetomidine 100 μg added to 0.5% 
Levobupivacaine in supraclavicular BPB has a 
faster onset & longer duration in terms of 
sensory & motor block. 
DISCUSSION
• The degree of sedation and vital signs does 
not significantly differ in both groups.
• However, Dexmedetomidine 100μg causes 
significant vasodilatation than 50μg group.
• This will ease the surgery & may result in an 
increased successful rate for AVF creation.
CONCLUSION
The addition of dexmedetomidine as an 
adjuvant for BPB:
 fasten the onset and prolong the duration of 
analgesia.
 produce sedative effect with stable 
haemodynamic parameters.
 increase the artery and vein diameters to 
ease AVF surgery.
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